• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ultra-high Potency Topical Corticosteroids as a Potential Trigger for Reactive Perforating Collagenosis.

作者信息

Madanchi Matiar, Curatolo Riccardo, Juratli Hazem A, Mangas Cristina, Mainetti Carlo

机构信息

Department of Dermatology, University Hospital Basel, Basel, Switzerland.

Dermatology and Oncology Department, Istituto Oncologico Svizzera Italiana (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.

出版信息

Acta Derm Venereol. 2024 Aug 23;104:adv40950. doi: 10.2340/actadv.v104.40950.

DOI:10.2340/actadv.v104.40950
PMID:39175452
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11358840/
Abstract
摘要

相似文献

1
Ultra-high Potency Topical Corticosteroids as a Potential Trigger for Reactive Perforating Collagenosis.超强效外用皮质类固醇作为反应性穿通性胶原病的潜在触发因素
Acta Derm Venereol. 2024 Aug 23;104:adv40950. doi: 10.2340/actadv.v104.40950.
2
A case of rheumatoid vasculitis with acquired reactive perforating collagenosis.一例类风湿性血管炎合并获得性反应性穿通性胶原病。
Mod Rheumatol. 2019 May;29(3):547-550. doi: 10.1080/14397595.2016.1245175. Epub 2016 Nov 23.
3
Acquired reactive perforating collagenosis with IgA nephropathy.获得性反应性穿通性胶原病合并IgA肾病
J Dermatol. 1998 Sep;25(9):597-600. doi: 10.1111/j.1346-8138.1998.tb02464.x.
4
Successful treatment of acquired reactive perforating collagenosis with topical benzoyl peroxide: A possible therapeutic action underlying structural and metabolic turnover.外用过氧化苯甲酰成功治疗获得性反应性穿通性胶原病：结构和代谢更新潜在的一种可能治疗作用。
J Dermatol. 2020 Jan;47(1):e12-e14. doi: 10.1111/1346-8138.15102. Epub 2019 Oct 9.
5
Reactive perforating collagenosis during erlotinib therapy.厄洛替尼治疗期间的反应性穿通性胶原病
Acta Derm Venereol. 2012 Mar;92(2):216-7. doi: 10.2340/00015555-1248.
6
[Corticosteroids in rheumatology].
Rev Med Suisse Romande. 1990 Apr;110(4):327-9.
7
Sirolimus-induced inflammatory papules with acquired reactive perforating collagenosis.西罗莫司诱导的炎性丘疹伴获得性反应性穿通性胶原病。
Dermatology. 2008;216(3):239-42. doi: 10.1159/000112934. Epub 2008 Jan 9.
8
Acquired reactive perforating collagenosis.获得性反应性穿通性胶原病
CMAJ. 2010 Mar 9;182(4):E184. doi: 10.1503/cmaj.091185. Epub 2010 Feb 16.
9
Acquired Perforating Collagenosis in Diabetes Mellitus.糖尿病中的获得性穿通性胶原病
Dtsch Arztebl Int. 2018 Jul 9;115(27-28):462. doi: 10.3238/arztebl.2018.0462.
10
Successful treatment of acquired reactive perforating collagenosis with doxycycline.强力霉素成功治疗获得性反应性穿通性胶原病。
Acta Derm Venereol. 2002;82(5):393-5. doi: 10.1080/000155502320624249.

本文引用的文献

1
Unraveling the Enigma of Perforating Itches: A Comprehensive Report of Reactive Perforating Collagenosis in Three Patients.揭开穿孔性瘙痒之谜：三例反应性穿孔性胶原病的综合报告
Cureus. 2023 Sep 1;15(9):e44531. doi: 10.7759/cureus.44531. eCollection 2023 Sep.
2
Reversion of glucocorticoid-induced senescence and collagen synthesis decrease by LY294002 is mediated through p38 in skin.LY294002 通过 p38 逆转糖皮质激素诱导的皮肤衰老和胶原合成减少
Int J Biol Sci. 2022 Oct 18;18(16):6102-6113. doi: 10.7150/ijbs.73915. eCollection 2022.
3
European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations.欧洲特应性皮炎指南（EuroGuiDerm）- 第二部分：非系统性治疗和特殊特应性皮炎患者人群的治疗建议。
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1904-1926. doi: 10.1111/jdv.18429. Epub 2022 Sep 3.
4
Unusual eruption in association with sorafenib: a case of acquired perforating dermatosis, reactive perforating collagenosis type.与索拉非尼相关的罕见皮疹：一例获得性穿通性皮肤病，反应性穿通性胶原病型。
Dermatol Online J. 2018 Dec 15;24(12):13030/qt8b40k5kg.
5
Acquired reactive perforating collagenosis associated with Hodgkin disease.获得性反应性穿通性胶原病伴霍奇金病
Clin Exp Dermatol. 2017 Dec;42(8):934-936. doi: 10.1111/ced.13192. Epub 2017 Jul 10.
6
Acquired perforating dermatosis: clinicopathological study of 31 cases, emphasizing pathogenesis and treatment.获得性穿孔性皮肤病：31 例临床病理研究，强调发病机制和治疗。
J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1757-1763. doi: 10.1111/jdv.14220. Epub 2017 Apr 10.
7
Side-effects of topical steroids: A long overdue revisit.外用糖皮质激素的副作用：姗姗来迟的再审视
Indian Dermatol Online J. 2014 Oct;5(4):416-25. doi: 10.4103/2229-5178.142483.
8
[Acquired reactive perforating collagenosis associated with diabetes mellitus and renal insufficiency requiring dialysis].[获得性反应性穿通性胶原病伴糖尿病和需要透析的肾功能不全]
Dtsch Med Wochenschr. 2007 Dec;132(49):2624-6. doi: 10.1055/s-2007-993108.
9
Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A review.局部应用皮质类固醇的临床药理学和药代动力学特性。综述。
Drugs. 1988;36 Suppl 5:51-61. doi: 10.2165/00003495-198800365-00011.
10
Effects of glucocorticosteroids on cultured human skin fibroblasts. V. Influence of anabolic steroids on the inhibitory effects of clobetasol-17-propionate on cell proliferation and collagen synthesis.
Arch Dermatol Res. 1979 Aug;266(1):75-82. doi: 10.1007/BF00412864.